Global Micro-Invasive Glaucoma Implants Market, By Procedure (Trabecular Micro-Bypass Shunt, Hydrus Micro-Stent, Trabectome, Gonioscopy-Assisted Transluminal Traculomotomy, Kahook Dual Blade, Trab 360, Ab-Interno Canaloplasty, Supraciliary Microstenting), Implant Model (Long, Thin Tube, Large), End- User (Eye Hospitals, Opthalmology Clinics, Outpatient Surgical Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Micro-Invasive Glaucoma Implants Market
The micro-invasive glaucoma implants market is expected to witness market growth at a rate of 30.1% in the forecast period of 2021 to 2028 and is expected to reach USD 1,186.00 million by 2028. Data Bridge Market Research report on micro-invasive glaucoma implants market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increase in the prevalence of glaucoma cases is escalating the growth of micro-invasive glaucoma implants market.
Micro-invasive glaucoma implants surgeries are generally performed for the treatment of the open- angle glaucoma which is done through an ab- interno approach. This is known to be safe and offers faster recovery as compared to the traditional methods. They generally lower the intraocular by increasing the flow or reducing the production of the aqueous humor.
The rise in the number of ophthalmic disorders and glaucoma cases across the globe acts as one of the major factors driving the growth of micro-invasive glaucoma implants market. The growth in geriatric population prone to such diseases and high adoption of micro-invasive glaucoma drainage implants owning to their safe process and fast recovery accelerate the micro-invasive glaucoma implants market growth. The increase in inclination towards minimal invasive procedures and rise in awareness regarding the disease and treatment further influence the micro-invasive glaucoma implants market. Additionally, growth in global population, increase in healthcare expenditure and surge in disposable income of people positively affect the micro-invasive glaucoma implants market. Furthermore, technological advancement and innovations extends profitable opportunity to the micro-invasive glaucoma implants market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the procedure and less awareness about glaucoma among people are the factors expected to obstruct the micro-invasive glaucoma implants market growth. Dearth of skilled and trained professionals is projected to challenge the micro-invasive glaucoma implants market in the forecast period of 2021-2028.
This micro-invasive glaucoma implants market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on micro-invasive glaucoma implants market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Micro-Invasive Glaucoma Implants Market Scope and Market Size
The micro-invasive glaucoma implants market is segmented on the basis of procedure, implant model and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of procedure, the micro-invasive glaucoma implants market is segmented into trabecular micro-bypass shunt, hydrus micro-stent, trabectome, gonioscopy-assisted transluminal traculomotomy, kahook dual blade, trab 360, ab-interno canaloplasty and supraciliary microstenting.
- On the basis of implant model, the micro-invasive glaucoma implants market is segmented into long, thin tube and large.
- On the basis of end- user, the micro-invasive glaucoma implants market is segmented into eye hospitals, opthalmology clinics and outpatient surgical centers.
Global Micro-Invasive Glaucoma Implants Market Country Level Analysis
The micro-invasive glaucoma implants market is analyzed and market size insights and trends are provided by country, procedure, implant model and end- user as referenced above.
The countries covered in the global micro-invasive glaucoma implants market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific is expected to witness high growth during the forecast period of 2021-2028 due to the rise in government healthcare expenditure, high population rising number of reported cases of blindness and increasing cataract surgeries in the region.
The country section of the micro-invasive glaucoma implants market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The micro-invasive glaucoma implants market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for micro-invasive glaucoma implants market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on micro-invasive glaucoma implants market. The data is available for historic period 2010-2019.
Competitive Landscape and Micro-Invasive Glaucoma Implants Market Share Analysis
The micro-invasive glaucoma implants market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to micro-invasive glaucoma implants market.
The major players covered in the micro-invasive glaucoma implants market report are Alcon, Bausch & Lomb Incorporated, Carl Zeiss AG, Johnson & Johnson Vision Care Inc, Lumenis, Glaukos Corporation, Ellex Medical Lasers, IRIDEX Corporation, HAAG-STREIT GROUP, Ziemer Ophthalmic Systems, Sonomed Escalon, HumanOptics, PhysIOL, Essilor, NIDEK CO., LTD., Santen Pharmaceutical Co., Ltd among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-